CeGaT GmbH welcomes Prof. Dr. Peter Freisinger as a new member of the Scientific Advisory Board.
Prof. Freisinger is the Physician-in-Chief of Pediatric Medicine in Reutlingen, Germany. He is specialized in metabolic and mitochondrial disorders, skeletal dysplasias, and neurodevelopmental diseases. Furthermore he has a focus on perinatal medicine in neonatology. Prof. Freisinger will consult CeGaT with respect to metabolic and mitochondrial diagostics.
CeGaT GmbH has upgraded its Next-Generation Sequencing Facility to the latest available technology of ABI / life technologies.
Now we are able to generate up to 100 billion base pairs per run. This means that the coverage per run has doubled and thus significantly more reads are generated for exome and transcriptome sequencing.